Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors
Soumya G Chikermane, Jieni Li, Rajender R Aparasu University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy, Houston, TX, USACorrespondence: Rajender R Aparasu, Department of Pharmaceutical Health Outcomes and Policy College of Pharmacy, University of Housto...
Saved in:
| Main Authors: | Chikermane SG, Li J, Aparasu RR |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Drug, Healthcare and Patient Safety |
| Subjects: | |
| Online Access: | https://www.dovepress.com/risk-of-antipsychotic-initiation-among-older-dementia-patients-initiat-peer-reviewed-fulltext-article-DHPS |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer’s disease dispensed by the Brazilian public health system – 2008 to 2014: a nation-wide analysis
by: Flávia Silva de Moraes, et al. -
Comparison of cholinesterase inhibitor safety in real‐world practice
by: Greg Carney, et al.
Published: (2019-01-01) -
Revisiting capsaicin and nonivamide: Their analogs exert strong inhibitory activity against cholinesterases
by: Niels V. Heise, et al.
Published: (2024-12-01) -
Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review
by: Maryam N. ALNasser, et al.
Published: (2025-02-01) -
Case Report: Lewy body dementia with unusual psychotic symptoms, atypically late parkinsonism, and patient sensitivity to first generation antipsychotics
by: Lolita Ercika, et al.
Published: (2025-04-01)